Epicardial fat thickness regression with continuous positive airway pressure therapy in patients with obstructive sleep apnea: assessment by two-dimensional echocardiography

Wiener Klinische Wochenschrift

Volumn 128, Issue 5-6, 2016, Pages 187-192

  Çetin, Süha ^a   Vural, Mustafa Gökhan ^b   Gündüz, Hüseyin ^b   Akdemir, Ramazan ^b   Fırat, Hikmet ^c  

^a Department of Cardiology   (Turkey)

^b SAKARYA UNIVERSITY   (Turkey)

^c Diskapi Yildirim Beyazit Educational and Research Hospital   (Turkey)

Author keywords

CPAP therapy; Epicardial fat thickness; Obstructive sleep apnea

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; DIASTOLIC BLOOD PRESSURE; EPICARDIAL FAT THICKNESS; EPICARDIUM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; SLEEP DISORDERED BREATHING; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; TRIACYLGLYCEROL BLOOD LEVEL; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ULTRASOUND TRANSDUCER; WAIST CIRCUMFERENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; ORGAN SIZE; PERICARDIUM; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; TURKEY;

CONTINUOUS POSITIVE AIRWAY PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; ORGAN SIZE; PERICARDIUM; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TURKEY;

EID: 84960457427     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-016-0975-z     Document Type: Article

References (33)

1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea. Am J Respir Crit Care. 2002;154:1217–39.
2. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001;163:19–25.
3. Partinen M, Guilleminault C. Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest. 1990;97:27–32.
4. Akilli H, Kayrak M, Bekci TT, Erdoğan HI, Aribas A, Yildirim O, et al. Gender-related changes of the epicardial fat thickness and leptin in obstructive sleep apnea. Echocardiography. 2014;31:411–9.
5. Coughlin SR, Mawdsley L, Mugarza JA, Carverley PMA, Wilding JPH. Obstructive apnoea is independently associated with increased prevalence of metabolic syndrome. Eur Heart J. 2004;25:735–41.
6. Kano M, Tatsumi K, Saibara T, Nakamur A, Tanabe N, Takiguchi Y, et al. Obstructive sleep apnoea syndrome is associated with some components of metabolic syndrome. Chest. 2007;131:1387–92.
7. Nakamura T, Takunaga K, Shimomura I, Nishida M, Yoshida S, Kotani K, et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis. 1994;107:239–46.
8. Pack AI, Pien GW. Update on sleep and its disorders. Annu Rev Med. 2011;62:447–60.
9. Mariani S, Fiori D, Barbaro G, Basciani S, Saponara M, D’Arcangelo E, et al. Association of epicardial fat thickness with the severity of obstructive sleep apnea in obese patients. Int J Cardiol. 2013;167:2244–9.
10. Lubrano C, Saponara M, Barbaro G, Specchia P, Addressi E, Constantini D, et al. Relationships between body fat distribution, epicardial fat and obstructive sleep apnea in obese patients with and without metabolic syndrome. PLoS One. 2012;7:e47059.
11. Park JS, Ahn SG, Hwang JW, Lim HS, Choi BJ, Choi SJ, et al. Impact of body mass index on the relationship of epicardial adipose tissue to metabolic syndrome and coronary artery disease in Asian population. Cardiovasc Diabetol. 2010;9:29.
12. Park JH, Park JS, Kim YJ, Lee IS, Kim JH, Choi SW, et al. Effects of statins on the epicardial fat thickness in patients coronary artery stenosis underwent percutaneous coronary intervention: comparison of atorvastatin with simvastatine/ezetimibe. J Cardiovasc Ultrasound. 2010;18:121–6.
13. Chin K, Shimuzu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway therapy. Circulation. 1999;100:706–12.
14. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection. evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation. 2002;106:3143–421.
15. Kushida CA, Chediak A, Berry RB, Brown LK, Gozal D, Iber C, Positive Airway Pressure Titration Task Force; American Academy of Sleep Medicine, et al. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med. 2008;4:157–71.
16. Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappatereno A, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003;88:5163–8.
17. Drager LF, Lopes HF, Maki-Nunes C, Trombetta IC, Toschi-Dias E, Alves MJ, et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One. 2010; 5:e12065.
18. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation. International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.
19. Nishimura S, Manabe I, Nagai R. Adipose tissue inflammation in obesity and metabolic syndrome. Discov Med. 2009;8:55–60.
20. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96:939–49.
21. Marchington JM, Mattacs CA, Pond CM. Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B. 1989;94(2):225–32.
22. Tanındı A, Kocaman SA, Erkan AF, Uğurlu M, Alhan A, Töre HF. Epicarial adipose tissue thickness is associated with myocardial infarction and impaired coronary perfusion. Anatol J Cardiol. 2015;15:224–31.
23. Çullu N, Kantarcı M, Kızrak Y, Pirimoğlu B, Ü B, Oğul H, et al. Does epicarial adipose tissue volume provide information about the presence and localization of coronary artery disease? Anatol J Cardiol. 2015;15:355–9.
24. Iacobellis G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol. 2015;11:363–71.
25. Kostopoulos K, Alhanatis E, Pampoukas K, Georgiopoulos G, Zourla A, Panoutsopoulos A, et al. CPAP therapy induces favorable short-term changes in epicardial thickness and vascular and metabolic markers in apparently healthy subjects with obstructive sleep apnea-hypopnea syndrome (OSAHS). Sleep Breath. doi:10.1007/s11325-015-1236-5.
26. Alexopoulos N, Melek BH, Arepalli CD, Hartlage GR, Chen Z, Kim S, et al. Effect of intensive versus moderate lipid-lovering therapy on epicardial adipse tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES trial (Beyond Endorsed Lipid Lowering with EBT Scanning). J Am Coll Cardiol. 2013;14:1956–61.
27. Koenig W, Sund M, Fröhlich M, Fischer HG, Löwel H, Döring A, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 1999;99:237–42.
28. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet. 1997;349:462–6.
29. Steiropoulos P, Tsara V, Nena E, Fitili C, Kataropoulou M, Froudarakis M, et al. Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest. 2007;132:843–51.
30. Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res. 2003;11:304–10.
31. Janik M, Hartlage G, Alexopoulos N, Mirzoyev Z, McLean DS, Arepalli CD, et al. Epicardial adipose tissue volume and coronary artery calcium to predict myocardial ischemia on positron emission tomography-computed tomography studies. J Nucl Cardiol. 2010;17:841–7.
32. Liang KW, Tsai IC, Lee WJ, Lee IT, Lin SY, Wan CJ, et al. MRI measured epicardial adipose tissue thickness at the right AV groove differentiates inflammatory status in obese men with metabolic syndrome. Obesity. 2012;20:525–32.
33. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, bimolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005;2:536–43.